Invesco Nasdaq Biotechnology ETF Rating $24.21 +0.41 (+1.72%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$24.21 +0.00 (+0.00%) As of 09/5/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy 2.69Holdings in IBBQ have an aggregate rating of Moderate Buy based on 444 analyst ratings issued in the past year covering 25 companies (64.9% of the portfolio).IBBQ Aggregate Price Target$24.21High Prediction$24.21Average Prediction$24.21Low Prediction$24.21Holdings in IBBQ have an aggregate price target of $24.21 and a range of $24.21 to $24.21 covering 25 companies (64.9% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.20%GILDGilead Sciences$115.05+2.0%4.9668 of 5 stars2.88$115.39 0.3%26Positive News6.98%AMGNAmgen$283.64+1.3%4.7348 of 5 stars2.32$304.43 7.3%22Positive NewsAnalyst Forecast6.25%VRTXVertex Pharmaceuticals$396.12-0.2%4.9711 of 5 stars2.56$497.10 25.5%27Positive NewsAnalyst Forecast6.21%REGNRegeneron Pharmaceuticals$573.38+1.1%4.7326 of 5 stars2.82$817.67 42.6%28Positive NewsAnalyst Upgrade5.23%ALNYAlnylam Pharmaceuticals$452.00-0.3%3.7959 of 5 stars2.85$417.38 -7.7%26Trending NewsAnalyst ForecastAnalyst Revision4.81%AZNAstraZeneca$81.70-0.1%2.5397 of 5 stars2.80$86.00 5.3%5Positive News2.50%INSMInsmed$145.10+1.8%3.5691 of 5 stars2.94$134.79 -7.1%17Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.26%ARGXargenex$750.78+2.3%3.9994 of 5 stars3.09$772.84 2.9%23Positive NewsAnalyst Forecast1.98%BIIBBiogen$140.67+0.5%4.7717 of 5 stars2.34$185.74 32.0%32Trending NewsAnalyst Forecast1.85%SMMTSummit Therapeutics$25.98+9.2%3.0834 of 5 stars2.65$33.79 30.0%17News CoveragePositive NewsAnalyst ForecastOptions Volume1.65%INCYIncyte$86.64+1.4%4.6128 of 5 stars2.33$82.53 -4.7%18Positive NewsAnalyst ForecastShort Interest ↑1.60%ILMNIllumina$98.93+1.3%4.8837 of 5 stars2.21$123.06 24.4%19Positive NewsAnalyst Forecast1.53%RPRXRoyalty Pharma$36.07-2.2%4.9827 of 5 stars3.33$48.00 33.1%3Positive NewsHigh Trading Volume1.43%SNYSanofi$46.50+2.6%4.0124 of 5 stars3.22$62.00 33.3%9Trending NewsAnalyst UpgradeShort Interest ↑Gap UpHigh Trading Volume1.41%UTHRUnited Therapeutics$400.52+5.3%4.4775 of 5 stars2.69$429.62 7.3%13Trending NewsAnalyst ForecastInsider TradeShort Interest ↑Analyst Revision1.40%NBIXNeurocrine Biosciences$144.10+2.6%4.7724 of 5 stars2.86$160.00 11.0%21Positive NewsAnalyst ForecastShort Interest ↑1.38%MEDPMedpace$486.98+1.0%4.3714 of 5 stars1.94$412.73 -15.2%16News CoverageAnalyst DowngradeInsider Trade1.26%TEMTempus AI$79.62+1.9%1.7278 of 5 stars2.54$69.50 -12.7%13Analyst Forecast1.25%VTRSViatris$10.50+1.6%1.5185 of 5 stars1.80$10.40 -1.0%51.25%ONCBeOne Medicines$341.80+7.2%1.2467 of 5 stars3.00$330.89 -3.2%7Analyst DowngradeGap Up1.20%ASNDAscendis Pharma A/S$205.91+3.9%3.4427 of 5 stars3.00$244.36 18.7%15News CoveragePositive NewsAnalyst Forecast1.13%BMRNBioMarin Pharmaceutical$57.77+1.8%4.9884 of 5 stars2.72$93.43 61.7%25News CoveragePositive NewsAnalyst Forecast1.05%EXELExelixis$37.88+1.3%4.8193 of 5 stars2.52$44.06 16.3%231.04%BNTXBioNTech$112.46+8.7%2.199 of 5 stars2.76$135.80 20.8%17News CoverageGap UpHigh Trading Volume1.02%BBIOBridgeBio Pharma$53.38+3.0%4.2405 of 5 stars3.00$63.35 18.7%17News CoveragePositive NewsAnalyst Forecast This page (NASDAQ:IBBQ) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
